About 7,323 results

ALLMedicine™ Sarcoidosis Center

Research & Reviews  2,521 results

Patient Activation for Self-Management in Patients with Idiopathic Pulmonary Fibrosis o...
Respiration; International Review of Thoracic Diseases; Bloem AEM, Mostard RLM et. al.

Sep 14th, 2021 - Self-management is considered important in the management of patients with idiopathic pulmonary fibrosis (IPF) or sarcoidosis. However, data about the degree of activation for self-management is lacking. The aim of the study was to determine the d...

Association of high serum soluble interleukin 2 receptor levels with risk of adverse ev...
ESC Heart Failure; Kobayashi Y, Sato T et. al.

Sep 14th, 2021 - Although soluble interleukin 2 receptor (sIL-2R) is a potentially useful biomarker in the diagnosis and evaluation of disease severity in patients with sarcoidosis, its prognostic implication in patients with cardiac sarcoidosis (CS) is unclear. W...

A fungal antigenic driver for Löfgren's syndrome sarcoidosis.
The Journal of Experimental Medicine; Lim CX, Weichhart T

Sep 14th, 2021 - Löfgren's syndrome is an acute form of sarcoidosis that is characterized by the activation of CD4+ T helper cells. In this issue of JEM, Greaves et al. (2021. J. Exp. Med.https://doi.org/10.1084/jem.20210785) identified a peptide derived from an a...

Lessons of the month 1: Longitudinal extensive transverse myelitis following AstraZenec...
Clinical Medicine (London, England); Notghi AA, Atley J et. al.

Sep 12th, 2021 - Longitudinal extensive transverse myelitis (LETM) is a rare but recognised complication of vaccination. We report the case of a 58-year-old man admitted to hospital 10 days after his first AstraZeneca COVID-19 vaccination with progressive neurolog...

see more →

Guidelines  3 results

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical ...
American Journal of Respiratory and Critical Care Medicine; Crouser ED, Maier LA et. al.

Apr 16th, 2020 - Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternativ...

2019 HRS expert consensus statement on evaluation, risk stratification, and management ...
Heart Rhythm; Towbin JA, McKenna WJ et. al.

May 13th, 2019 - Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders....

Consensus statement on surgical pathology of the aorta from the Society for Cardiovascu...
Cardiovascular Pathology : the Official Journal of the So... Stone JR, Bruneval P et. al.

Jun 9th, 2015 - Inflammatory diseases of the aorta include routine atherosclerosis, aortitis, periaortitis, and atherosclerosis with excessive inflammatory responses, such as inflammatory atherosclerotic aneurysms. The nomenclature and histologic features of thes...

see more →

Drugs  210 results see all →

Clinicaltrials.gov  5 results

Endobronchial Ultrasound Transbronchial Needle Aspiration Of Enlarged Mediastinal In Interstitial Lung Disease

Oct 23rd, 2020 - The aim of this study is to assess the findings of mediastinal/hilar LN sampling by EBUS-TBNA in patients with non-sarcoidosis interstitial lung disease ( ILD) who demonstrate LN enlargement on chest imaging. Patients with non-sarcoidosis ILD refe...

Development of the Danish Prospective Sarcoidosis Registry and Baseline Characteristics of a Danish Sarcoidosis Cohort

Jul 7th, 2020 - Development of a Danish Sarcoidosis Registry. Characterization of a cohort of sarcoidosis patients with respect to the baseline epidemiological characteristics, comorbidities, radiology, histopathology, diagnostic investigations and treatment.

Validation of King's Sarcoidosis Questionnaire in a Danish Population

May 14th, 2020 - The King's Sarcoidosis Questionnaire (KSQ) is a brief questionnaire assessing health status in patients with sarcoidosis. The KSQ was previously validated in English German and Dutch. KSQ will be translated into Danish and validated in a Danish sa...

Patient Reported Outcome Instruments in Sarcoidosis

Apr 13th, 2020 - Evaluate change of quality of life of sarcoiodosis patients over a six months using various quality of life instruments including a monthly smart phone app.

Prediction Model of CP-EBUS in the Diagnosis of Lymph Nodes

Apr 2nd, 2020 - Intrathoracic LNs enlargement has a wide range of diseases, among which intrathoracic LNs metastasis of lung cancer is the most common malignant disease. Benign lesions, including inflammation, tuberculosis and sarcoidosis, also need to be differe...

see more →

News  184 results

Tofacitinib: Small Study Shows Big Cutaneous Sarcoidosis Response

May 5th, 2021 - Researchers are reporting impressive results in a small, open-label trial of the JAK inhibitor tofacitinib in cutaneous sarcoidosis: 6 of 10 patients improved so much that they reached a disease activity level of zero, and all patients improved by...

Suspect Sarcoidosis? Here's What to Assess

Apr 28th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: We are back. This is The Curbsiders. I'm Dr Matthew Watto, here with my good friend, Dr Paul Williams. We're going to talk about sarcoidosis. We had a wonderful conversation with t...

Black Patients With Cutaneous Sarcoidosis May Have More Systemic and CV Disease

Apr 16th, 2021 - Black patients diagnosed by dermatologists with cutaneous sarcoidosis were significantly more likely to have unrecognized systemic organ involvement than were non-Black patients, according to a retrospective chart review of patients seen at Massac...

Fired for Good Judgment a Sign of Physicians' Lost Respect

Feb 23rd, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. What happened to Hasan Gokal, MD, should stick painfully in the craws of all physicians. It should serve as a call to action because Gokal is sit...

Checkpoint Inhibitor Safety in Preexisting Autoimmune Diseases

Feb 17th, 2021 - Patients with advanced melanoma and preexisting autoimmune diseases (AIDs) who were treated with immune checkpoint inhibitors (ICIs) responded well and did not suffer more grade 3 or higher immune-related adverse events than patients without an AI...

see more →

Patient Education  6 results see all →